• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国早期胃印戒细胞癌的淋巴结转移发生率、生存率及相关预测因素。

Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US.

机构信息

Emory University School of Medicine, Atlanta, GA, USA.

The Winship Cancer Institute, Emory University, Atlanta, GA, USA.

出版信息

J Gastrointest Surg. 2018 Apr;22(4):569-577. doi: 10.1007/s11605-017-3500-4. Epub 2018 Jan 8.

DOI:10.1007/s11605-017-3500-4
PMID:29313289
Abstract

INTRODUCTION

The incidence, survival, and propensity for nodal metastasis in early-stage gastric signet ring cell carcinoma have not been defined in the United States. These data are critical determinants for treatment allocation.

METHODS

Cases of gastric signet ring cell carcinoma were extracted from the national SEER database for the years 2004-2013. Age-standardized incidence was derived. Survival was calculated using the Kaplan-Meier method. Univariate and multivariate analyses were performed to identify predictors of nodal metastasis. Exclusion criteria included neoadjuvant radiotherapy and lack of histologic or nodal data.

RESULTS

A total of 10,624 cases were initially identified. The analysis cohort included 506 cases with early T-stage N0M0 disease following exclusions. The incidence was 0.094 per 100,000 person-years. The 5-year survival rate was 82.8%. Tumor stage (p < 0.001) and size (p < 0.001) were independent predictors of nodal metastasis. The incidence of nodal involvement for T1a tumors <2 cm was 5.4% (p < 0.004).

CONCLUSION

The incidence of potentially resectable signet ring gastric carcinoma has not changed significantly over the past decade. While presenting with predominantly high-grade histology, early T-stage disease has a high survival rate. Small T1a tumors have low rates of nodal metastasis, suggesting that an endoscopic resection could be considered in this subset.

摘要

简介

在美国,早期胃印戒细胞癌的发病率、生存率和淋巴结转移倾向尚未确定。这些数据是治疗分配的关键决定因素。

方法

从 2004 年至 2013 年的国家 SEER 数据库中提取胃印戒细胞癌病例。得出年龄标准化发病率。使用 Kaplan-Meier 方法计算生存率。进行单因素和多因素分析,以确定淋巴结转移的预测因素。排除标准包括新辅助放疗和缺乏组织学或淋巴结数据。

结果

最初确定了 10624 例病例。分析队列包括排除后具有早期 T 期 N0M0 疾病的 506 例。发病率为每 100,000 人年 0.094 例。5 年生存率为 82.8%。肿瘤分期(p<0.001)和大小(p<0.001)是淋巴结转移的独立预测因素。肿瘤大小<2cm 的 T1a 肿瘤的淋巴结受累发生率为 5.4%(p<0.004)。

结论

在过去十年中,潜在可切除的印戒细胞胃癌的发病率没有明显变化。尽管主要表现为高级别组织学,但早期 T 期疾病的生存率较高。小 T1a 肿瘤淋巴结转移率低,提示在这一亚组中可以考虑内镜下切除。

相似文献

1
Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US.美国早期胃印戒细胞癌的淋巴结转移发生率、生存率及相关预测因素。
J Gastrointest Surg. 2018 Apr;22(4):569-577. doi: 10.1007/s11605-017-3500-4. Epub 2018 Jan 8.
2
Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis.早期胃癌的黏膜内印戒细胞癌经内镜切除治疗是否合理?淋巴结转移相关因素分析。
Eur J Gastroenterol Hepatol. 2009 Oct;21(10):1132-5. doi: 10.1097/MEG.0b013e32832a21d8.
3
Risk Factors for Lymph Node Metastasis in Early Gastric Cancer with Signet Ring Cell Carcinoma.早期胃印戒细胞癌淋巴结转移的危险因素
J Gastrointest Surg. 2015 Nov;19(11):1958-65. doi: 10.1007/s11605-015-2915-z.
4
Applicability of endoscopic submucosal dissection for undifferentiated early gastric cancer: Mixed histology of poorly differentiated adenocarcinoma and signet ring cell carcinoma is a worse predictive factor of nodal metastasis.内镜黏膜下剥离术治疗未分化早期胃癌的适用性:低分化腺癌和印戒细胞癌的混合组织学类型是淋巴结转移的更差预测因素。
Surg Oncol. 2017 Mar;26(1):8-12. doi: 10.1016/j.suronc.2016.12.001. Epub 2016 Dec 8.
5
Predictors of Lymph Node Metastasis and Differences Between Pure and Mixed Histologic Types of Early Gastric Signet-ring Cell Carcinomas.早期胃印戒细胞癌的纯和混合组织学类型之间的淋巴结转移预测因子及差异。
Am J Surg Pathol. 2020 Jul;44(7):934-942. doi: 10.1097/PAS.0000000000001460.
6
Lymph node metastasis in early gastric adenocarcinoma in the United States of America.美国早期胃腺癌的淋巴结转移。
Endoscopy. 2018 May;50(5):479-486. doi: 10.1055/s-0043-122379. Epub 2017 Dec 11.
7
Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology.早期胃癌印戒细胞组织学类型患者行根治性切除术后的临床病理特征及预后
J Visc Surg. 2015 Dec;152(6):357-61. doi: 10.1016/j.jviscsurg.2015.09.021. Epub 2015 Oct 23.
8
Incidence of lymph node metastasis in intramucosal gastric cancer measuring 30 mm or less, with ulceration; mixed, predominantly differentiated-type histology; and no lymphovascular invasion: a multicenter retrospective study.肿瘤大小30mm及以下、伴有溃疡、组织学类型为混合型且以分化型为主、无淋巴管浸润的黏膜内胃癌的淋巴结转移发生率:一项多中心回顾性研究
Gastric Cancer. 2016 Oct;19(4):1144-1148. doi: 10.1007/s10120-015-0569-x. Epub 2015 Nov 17.
9
Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma.未分化型黏膜胃癌的淋巴结转移风险。
World J Surg Oncol. 2019 Feb 13;17(1):32. doi: 10.1186/s12957-019-1571-2.
10
Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria.满足日本内镜切除标准的美国早期胃癌患者中淋巴结转移的低频率。
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1763-1769. doi: 10.1016/j.cgh.2018.11.031. Epub 2018 Nov 22.

引用本文的文献

1
Prognostic prediction and treatment options for gastric signet ring cell carcinoma: a SEER database analysis.胃印戒细胞癌的预后预测与治疗选择:一项监测、流行病学和最终结果(SEER)数据库分析
Front Oncol. 2024 Oct 21;14:1473798. doi: 10.3389/fonc.2024.1473798. eCollection 2024.
2
The prognostic value of FAR and a novel FAR-CA125 score in resectable gastric signet ring cell carcinoma patients.可切除胃印戒细胞癌患者中 FAR 和新型 FAR-CA125 评分的预后价值。
J Cancer Res Clin Oncol. 2023 Sep;149(12):9597-9608. doi: 10.1007/s00432-023-04870-4. Epub 2023 May 24.
3
An Evaluation of Fluorouracil plus Paclitaxel and Oxiliplatin as a First-Line Treatment for Advanced Gastric Squamous Cell Carcinoma.
氟尿嘧啶联合紫杉醇和奥沙利铂作为晚期胃鳞状细胞癌一线治疗方案的评估
Evid Based Complement Alternat Med. 2023 Apr 6;2023:2176371. doi: 10.1155/2023/2176371. eCollection 2023.
4
Pathological Nodal Staging Score for Gastric Signet Ring Cell Carcinoma: A Clinical Tool of Adequate Nodal Staging.胃印戒细胞癌的病理性淋巴结分期评分:一种充分进行淋巴结分期的临床工具。
Diagnostics (Basel). 2022 Sep 22;12(10):2289. doi: 10.3390/diagnostics12102289.
5
Clinicopathological characteristics of signet-ring cell carcinoma derived from gastric fovelar epithelium.胃黏膜固有层腺窝来源的印戒细胞癌的临床病理特征。
J Dig Dis. 2022 Jul;23(7):396-403. doi: 10.1111/1751-2980.13120.
6
The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma.胃印戒细胞癌患者基于发病率的死亡率和生存趋势
J Oncol. 2022 May 28;2022:3308801. doi: 10.1155/2022/3308801. eCollection 2022.
7
Positive lymph node ratio as a novel indicator of prognosis in gastric signet ring cell carcinoma: a population-based retrospective study.阳性淋巴结比率作为胃印戒细胞癌预后的新指标:一项基于人群的回顾性研究。
Transl Cancer Res. 2020 May;9(5):3658-3668. doi: 10.21037/tcr.2020.04.04.
8
Quantifying the cell morphology and predicting biological behavior of signet ring cell carcinoma using deep learning.利用深度学习量化印戒细胞癌的细胞形态并预测其生物学行为。
Sci Rep. 2022 Jan 7;12(1):183. doi: 10.1038/s41598-021-03984-4.
9
Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges.胃和胃食管交界处的印戒细胞癌:分子改变、分层治疗方法和未来挑战。
Langenbecks Arch Surg. 2022 Feb;407(1):87-98. doi: 10.1007/s00423-021-02314-6. Epub 2021 Sep 10.
10
Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges.胃印戒细胞癌:当前治疗与未来挑战
Cancer Manag Res. 2020 Sep 3;12:7973-7981. doi: 10.2147/CMAR.S268032. eCollection 2020.